Article
A robust computational quest: Discovering potential hits to improve the treatment of pyrazinamide-resistant Mycobacterium tuberculosis.
Journal of cellular and molecular medicine - 1 Apr 2024
Shahab Muhammad, de Farias Morais Gabriel Christian, Akash Shopnil, Fulco Umberto Laino, Oliveira Jonas Ivan Nobre, Zheng Guojun, Akter Shahina
Abstract excerpt
The rise of pyrazinamide (PZA)-resistant strains of Mycobacterium tuberculosis (MTB) poses a major challenge to conventional tuberculosis (TB) treatments. PZA, a cornerstone of TB therapy, must be activated by the mycobacterial enzyme pyrazinamidase (PZase) to convert its active form, pyrazinoic acid, which targets the ribosomal protein S1. Resistance, often associated with mutations in the RpsA protein,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
